Unibest
← Back to patent-cliff list

CAS 1342316-08-8

Methyl N-benzoyl-3-(2-chlorocyclopent-1-en-1-yl)-L-alaninate

Codes: Ramipril-052

Application context (from source-drug indications)

HypercholesterolaemiaAtorvastatin Calcium Hydrate/RamiprilHypertensionAtorvastatin Calcium Hydrate/RamiprilHypertensionRamiprilNephropathyRamiprilMyocardial infarctionRamiprilHeart failureRamiprilStrokeRamiprilMitral stenosisRamipril

Source drugs (routes using this intermediate)

DrugTierExpiry
Atorvastatin Calcium Hydrate/RamiprilTier C — Watch / trade-
RamiprilTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Atorvastatin Calcium Hydrate/RamiprilOptimised routesteps: 1total yield: /
Methyl (2Z)-2-(benzoylamino)-3-(2-chlorocyclopent-1-en-1-yl)acrylate→Methyl N-benzoyl-3-(2-chlorocyclopent-1-en-1-yl)-L-alaninate
Atorvastatin Calcium Hydrate/RamiprilOptimised routesteps: 1total yield: 219.3g(Ramipril-055)
RamiprilOptimised routesteps: 1total yield: /
Methyl (2Z)-2-(benzoylamino)-3-(2-chlorocyclopent-1-en-1-yl)acrylate→Methyl N-benzoyl-3-(2-chlorocyclopent-1-en-1-yl)-L-alaninate
RamiprilOptimised routesteps: 1total yield: 219.3g(Ramipril-055)

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.